FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135008444> ?p ?o ?g. }

• W3135008444 abstract "Hemorrhagic shock and its complications are a major cause of death among trauma patients. The management of hemorrhagic shock using a damage control resuscitation strategy has been shown to decrease mortality and improve patient outcomes. One of the components of damage control resuscitation is hemostatic resuscitation, which involves the replacement of lost blood volume with components such as packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets in a 1:1:1:1 ratio. However, this is a strategy that is not applicable in many parts of Latin America and other low-and-middle-income countries throughout the world, where there is a lack of well-equipped blood banks and an insufficient availability of blood products. To overcome these barriers, we propose the use of cold fresh whole blood for hemostatic resuscitation in exsanguinating patients. Over 6 years of experience in Ecuador has shown that resuscitation with cold fresh whole blood has similar outcomes and a similar safety profile compared to resuscitation with hemocomponents. Whole blood confers many advantages over component therapy including, but not limited to the transfusion of blood with a physiologic ratio of components, ease of transport and transfusion, less volume of anticoagulants and additives transfused to the patient, and exposure to fewer donors. Whole blood is a tool with reemerging potential that can be implemented in civilian trauma centers with optimal results and less technical demand.El choque hemorrágico y sus complicaciones son la principal causa de muerte en los pacientes con trauma. La resucitación en control de daños ha demostrado una disminución en la mortalidad y mejoría en el manejo del paciente. La resucitación hemostática consiste en la recuperación del volumen con hemoderivados como glóbulos rojos, plasma, crioprecipitado y plaquetas, en proporciones de 1:1:1:1. Sin embargo, esta demanda de hemo componentes podría no aplicarse para toda Latinoamérica u otros países de medianos y bajos ingresos. Las principales barreras para la implementación de esta estrategia serían la escasa disponibilidad de bancos de sangre y de hemoderivados insuficientes para contar con un protocolo de transfusión masiva. Una propuesta para superar estas barreras es el uso de sangre total fresca fría para la resucitación hemostática de los pacientes exsanguinados. Ecuador ha sido pionero en la implementación de esta estrategia con una experiencia ya de seis años, en que han demostrado que la sangre total tiene ventajas sobre la terapia de hemo componentes incluyendo, pero no limitando, la trasfusión de sangre con una razón fisiológica de componentes, fácil transporte y transfusión, menor volumen de anticoagulantes y aditivos trasfundidos al paciente, y menor exposición a donantes. La sangre total es una herramienta con un potencial reemergente que puede ser implementado en centros de trauma civil con óptimos resultados y menor demanda técnica." @default.
• W3135008444 created "2021-03-15" @default.
• W3135008444 creator A5004508646 @default.
• W3135008444 creator A5004952064 @default.
• W3135008444 creator A5012586912 @default.
• W3135008444 creator A5016923163 @default.
• W3135008444 creator A5024785458 @default.
• W3135008444 creator A5028849873 @default.
• W3135008444 creator A5031880576 @default.
• W3135008444 creator A5032187332 @default.
• W3135008444 creator A5038687530 @default.
• W3135008444 creator A5039667663 @default.
• W3135008444 creator A5053020192 @default.
• W3135008444 creator A5054555078 @default.
• W3135008444 creator A5054680348 @default.
• W3135008444 creator A5056497705 @default.
• W3135008444 date "2020-08-21" @default.
• W3135008444 modified "2023-09-27" @default.
• W3135008444 title "Whole Blood for Blood Loss: Hemostatic Resuscitation in Damage Control" @default.
• W3135008444 cites W1498007396 @default.
• W3135008444 cites W1745043703 @default.
• W3135008444 cites W1765112728 @default.
• W3135008444 cites W1791237567 @default.
• W3135008444 cites W1878788733 @default.
• W3135008444 cites W1981714421 @default.
• W3135008444 cites W1983515167 @default.
• W3135008444 cites W2018525094 @default.
• W3135008444 cites W2024808820 @default.
• W3135008444 cites W2049530561 @default.
• W3135008444 cites W2081522104 @default.
• W3135008444 cites W2084280207 @default.
• W3135008444 cites W2091685079 @default.
• W3135008444 cites W2092131749 @default.
• W3135008444 cites W2101654172 @default.
• W3135008444 cites W2122147172 @default.
• W3135008444 cites W2133226878 @default.
• W3135008444 cites W2137394990 @default.
• W3135008444 cites W2143268759 @default.
• W3135008444 cites W2152704049 @default.
• W3135008444 cites W2156967952 @default.
• W3135008444 cites W2324226739 @default.
• W3135008444 cites W2324829729 @default.
• W3135008444 cites W2342783716 @default.
• W3135008444 cites W2402685340 @default.
• W3135008444 cites W2468169580 @default.
• W3135008444 cites W2507723960 @default.
• W3135008444 cites W2537594830 @default.
• W3135008444 cites W2555737727 @default.
• W3135008444 cites W2555777785 @default.
• W3135008444 cites W2775942879 @default.
• W3135008444 cites W2802431840 @default.
• W3135008444 cites W2889270457 @default.
• W3135008444 cites W2890587658 @default.
• W3135008444 cites W2938028646 @default.
• W3135008444 cites W2966183440 @default.
• W3135008444 cites W2971194517 @default.
• W3135008444 cites W2980678050 @default.
• W3135008444 cites W2998672414 @default.
• W3135008444 cites W3006953388 @default.
• W3135008444 cites W3023771142 @default.
• W3135008444 cites W3118599331 @default.
• W3135008444 doi "https://doi.org/10.25100/cm.v51i4.4511" @default.
• W3135008444 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7968429" @default.
• W3135008444 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33795899" @default.
• W3135008444 hasPublicationYear "2020" @default.
• W3135008444 type Work @default.
• W3135008444 sameAs 3135008444 @default.
• W3135008444 citedByCount "5" @default.
• W3135008444 countsByYear W31350084442021 @default.
• W3135008444 countsByYear W31350084442022 @default.
• W3135008444 countsByYear W31350084442023 @default.
• W3135008444 crossrefType "journal-article" @default.
• W3135008444 hasAuthorship W3135008444A5004508646 @default.
• W3135008444 hasAuthorship W3135008444A5004952064 @default.
• W3135008444 hasAuthorship W3135008444A5012586912 @default.
• W3135008444 hasAuthorship W3135008444A5016923163 @default.
• W3135008444 hasAuthorship W3135008444A5024785458 @default.
• W3135008444 hasAuthorship W3135008444A5028849873 @default.
• W3135008444 hasAuthorship W3135008444A5031880576 @default.
• W3135008444 hasAuthorship W3135008444A5032187332 @default.
• W3135008444 hasAuthorship W3135008444A5038687530 @default.
• W3135008444 hasAuthorship W3135008444A5039667663 @default.
• W3135008444 hasAuthorship W3135008444A5053020192 @default.
• W3135008444 hasAuthorship W3135008444A5054555078 @default.
• W3135008444 hasAuthorship W3135008444A5054680348 @default.
• W3135008444 hasAuthorship W3135008444A5056497705 @default.
• W3135008444 hasBestOaLocation W31350084441 @default.
• W3135008444 hasConcept C126322002 @default.
• W3135008444 hasConcept C141071460 @default.
• W3135008444 hasConcept C1621761 @default.
• W3135008444 hasConcept C177713679 @default.
• W3135008444 hasConcept C194828623 @default.
• W3135008444 hasConcept C2778165595 @default.
• W3135008444 hasConcept C2778258694 @default.
• W3135008444 hasConcept C2780014101 @default.
• W3135008444 hasConcept C2780920261 @default.
• W3135008444 hasConcept C2781300812 @default.
• W3135008444 hasConcept C2993366118 @default.
• W3135008444 hasConcept C37557685 @default.
• W3135008444 hasConcept C42219234 @default.

• next